Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-18

Clinical Trial Update: The POWERED Study: Prophylaxis With Metformin to Prevent PTDM [Phase 2]

View source ↗

Summary

Phase 2 trial update on using metformin prophylaxis to prevent post-transplant diabetes mellitus after kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Post-transplant Diabetes Mellitus, New Onset Diabetes After Transplant | Phase 2 | Status: COMPLETED